查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589789

酵素结合免疫吸附检测法市场：按测试类型和应用划分 - 2025-2030 年全球预测

Enzyme-linked Immunosorbent Assay Testing Market by Test Type (Competitive ELISA, Indirect ELISA, Multiple & Portable ELISA), Application (Cancer, Immunology, Infectious Diseases) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年酵素结合免疫吸附检测法市值为5,1639万美元，预计2024年将达55,258万美元，复合年增长率为7.10%，到2030年将达到83477万美元，预计将达到1000万美元。

酵素结合免疫吸附检测法(ELISA) 市场与用于检测和定量蛋白质、荷尔蒙、抗体和抗原等物质的技术相关。 ELISA 的重要性在于其高准确度、易用性和高通量筛检的自动化能力，使其在诊断、製药和食品工业应用中至关重要。在诊断学中，ELISA 用于诊断感染疾病和慢性病等疾病，在医学中用于开发药物和疫苗，在食品工业中用于检测过敏原和污染物。由于慢性病的增加、研究的进步、对具有成本效益的诊断工具的需求不断增加以及生物技术和製药行业的扩张，市场正在扩大。关键的成长要素包括微孔盘自动化等技术进步以及提高检测能力的检测形式的创新。此外，对照护现场诊断的需求不断增长，为市场相关人员提供了开发快速检测解决方案的潜在机会。

主要市场统计
基准年[2023] 51639万美元
预测年份 [2024] 55258万美元
预测年份 [2030] 8.3477 亿美元
复合年增长率（%） 7.10%

然而，市场面临阻碍成长的限制，包括高昂的测试成本、对熟练专业人员的需求以及监管限制。测试程序的复杂性和交叉反应的可能性也带来了挑战，从而降低了某些应用的可靠性。能够同时检测多种分析物的多重功能创新是研究和业务成长的一个有前景的领域。此外，提高检测灵敏度和特异性提供了提高市场渗透率的机会。市场需要不断创新来克服竞争压力，数位化和自动化解决方案的日益整合可能会影响未来的发展。总体而言，ELISA市场是一个充满活力和竞争的市场，要求企业专注于技术创新和以客户为中心的解决方案，以抓住新机会并有效应对现有挑战。

市场动态：揭示快速发展的酵素结合免疫吸附检测法市场的关键市场洞察

供需的动态交互作用正在改变酵素结合免疫吸附检测法市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病率增加
    • 需要具有成本效益的诊断工具
    • 政府支持基础建设发展和扩大治疗倡议
  • 市场限制因素
    • 基础设施缺乏
  • 市场机会
    • 持续开发并推出 ELISA 测试
    • 基于影像分析的低成本可携式ELISA 阅读器的成长潜力
  • 市场挑战
    • 复杂的检测开发工作流程

波特的五力：驾驭酵素结合免疫吸附检测法市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解酵素结合免疫吸附检测法市场的外部影响

外部宏观环境因素在塑造酵素结合免疫吸附检测法市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解酵素结合免疫吸附检测法市场的竞争状况

酵素结合免疫吸附检测法市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位酵素结合免疫吸附检测法市场供应商的绩效评估

FPNV定位矩阵是评估酵素结合免疫吸附检测法市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，为酵素结合免疫吸附检测法市场的成功指明道路

对于旨在加强其在全球市场的影响力的公司来说，酵素结合免疫吸附检测法市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病率增加
      • 需要具有成本效益的诊断工具
      • 政府支持加强基础设施和治疗工作
    • 抑制因素
      • 基础设施缺乏
    • 机会
      • ELISA 测试的持续开发和实施
      • 基于影像分析的低成本可携式ELISA 阅读器的潜在成长
    • 任务
      • 复杂的检测开发工作流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依测试类型酵素结合免疫吸附检测法

  • 竞争性ELISA
  • 间接ELISA
  • 多重可携式ELISA
  • 夹心ELISA

第七章酵素结合免疫吸附检测法市场：依应用分类

  • 癌症
  • 免疫学
  • 感染疾病
  • 发炎
  • 蛋白质定量

第八章 美洲酵素结合免疫吸附检测法市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区酵素结合免疫吸附检测法市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的酵素结合免疫吸附检测法市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abcam
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • bioMerieux, Inc.
  • Enzo Life Sciences, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • PerkinElmer
  • RayBiotech Life Inc.
  • Shenzhen YHLO Biotech Co., Ltd.
  • Thermo Fisher Scientific. Inc.
  • ZEUS Scientific, Inc. by Sebia
Product Code: MRR-4348D129FABF

The Enzyme-linked Immunosorbent Assay Testing Market was valued at USD 516.39 million in 2023, expected to reach USD 552.58 million in 2024, and is projected to grow at a CAGR of 7.10%, to USD 834.77 million by 2030.

The enzyme-linked immunosorbent assay (ELISA) testing market pertains to technologies used for detecting and quantifying substances such as proteins, hormones, antibodies, and antigens. ELISA's importance stems from its precision, ease of use, and ability to be automated for high-throughput screening, making it essential in diagnostics, pharmaceuticals, and food industry applications. In diagnostics, ELISA is used for disease diagnosis, including infections and chronic conditions; in pharmaceuticals, for drug and vaccine development; and in the food industry, for detecting allergens and contaminants. The market is growing due to increasing incidences of chronic diseases, advancements in research, a rise in demand for cost-effective diagnostic tools, and expansion in the biotechnology and pharmaceutical industries. Key growth factors include technological advancements like microplate automation and innovations in assay formats which enhance testing capabilities. Moreover, the rising demand for point-of-care diagnostics provides potential opportunities for market players to develop rapid assay solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 516.39 million
Estimated Year [2024] USD 552.58 million
Forecast Year [2030] USD 834.77 million
CAGR (%) 7.10%

However, the market faces limitations such as the high cost of testing, the need for skilled professionals, and regulatory constraints which can hinder growth. Challenges also arise from the complex nature of testing procedures and the potential for cross-reactivity, reducing reliability in some applications. Innovating in multiplexing capabilities to allow simultaneous detection of multiple analytes is a promising area for research and business growth. Additionally, improving assay sensitivity and specificity presents opportunities to enhance market penetration. The market demands constant innovation to stay ahead of competitive pressures, with increasing integration of digital and automated solutions likely to shape future developments. Overall, the ELISA market is dynamic and competitive, requiring firms to focus on technological innovation and customer-centric solutions to capture emerging opportunities and address existing challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enzyme-linked Immunosorbent Assay Testing Market

The Enzyme-linked Immunosorbent Assay Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence rate of infectious diseases
    • Need for cost-effective diagnostic tools
    • Government support in increasing infrastructure and treatment initiatives
  • Market Restraints
    • Lack of infrastructural faciltities
  • Market Opportunities
    • Ongoing developments and launches of the ELISA testing
    • Potential growth for low-cost portable ELISA reader based on image analysis
  • Market Challenges
    • Complex assay development workflows

Porter's Five Forces: A Strategic Tool for Navigating the Enzyme-linked Immunosorbent Assay Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enzyme-linked Immunosorbent Assay Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enzyme-linked Immunosorbent Assay Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enzyme-linked Immunosorbent Assay Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enzyme-linked Immunosorbent Assay Testing Market

A detailed market share analysis in the Enzyme-linked Immunosorbent Assay Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enzyme-linked Immunosorbent Assay Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enzyme-linked Immunosorbent Assay Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enzyme-linked Immunosorbent Assay Testing Market

A strategic analysis of the Enzyme-linked Immunosorbent Assay Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enzyme-linked Immunosorbent Assay Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam, Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne Corporation, bioMerieux, Inc., Enzo Life Sciences, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Merck KGaA, PerkinElmer, RayBiotech Life Inc., Shenzhen YHLO Biotech Co., Ltd., Thermo Fisher Scientific. Inc., and ZEUS Scientific, Inc. by Sebia.

Market Segmentation & Coverage

This research report categorizes the Enzyme-linked Immunosorbent Assay Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Competitive ELISA, Indirect ELISA, Multiple & Portable ELISA, and Sandwich ELISA.
  • Based on Application, market is studied across Cancer, Immunology, Infectious Diseases, Inflammation, and Protein Quantitation.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence rate of infectious diseases
      • 5.1.1.2. Need for cost-effective diagnostic tools
      • 5.1.1.3. Government support in increasing infrastructure and treatment initiatives
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of infrastructural faciltities
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing developments and launches of the ELISA testing
      • 5.1.3.2. Potential growth for low-cost portable ELISA reader based on image analysis
    • 5.1.4. Challenges
      • 5.1.4.1. Complex assay development workflows
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Enzyme-linked Immunosorbent Assay Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Competitive ELISA
  • 6.3. Indirect ELISA
  • 6.4. Multiple & Portable ELISA
  • 6.5. Sandwich ELISA

7. Enzyme-linked Immunosorbent Assay Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Immunology
  • 7.4. Infectious Diseases
  • 7.5. Inflammation
  • 7.6. Protein Quantitation

8. Americas Enzyme-linked Immunosorbent Assay Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Enzyme-linked Immunosorbent Assay Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Enzyme-linked Immunosorbent Assay Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam
  • 2. Agilent Technologies Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories
  • 5. Bio-Techne Corporation
  • 6. bioMerieux, Inc.
  • 7. Enzo Life Sciences, Inc.
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche AG
  • 10. Merck KGaA
  • 11. PerkinElmer
  • 12. RayBiotech Life Inc.
  • 13. Shenzhen YHLO Biotech Co., Ltd.
  • 14. Thermo Fisher Scientific. Inc.
  • 15. ZEUS Scientific, Inc. by Sebia

LIST OF FIGURES

  • FIGURE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MULTIPLE & PORTABLE ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PROTEIN QUANTITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2023